The Gym Group: a genuinely better business, but the stock has already priced the expansion

The Gym Group's half-year results, released on 9 September, were strong enough to send the shares up about 8% to roughly 207p — within a few pence of the 220p 52-week high, and up from the 131p 52-week low. That is a move of nearly 60% off the bottom for the UK's low-cost, 24/7, no-contract gym chain.

The instinct when a company reports a good quarter and the stock jumps is to reach for the "cheap and improving" story. This is not that story. The business has genuinely gotten better; the question a new buyer has to face is that the price has run ahead of the proof.

The quarter was real, not promotional

Start with what the numbers actually show, because on fundamentals this is a well-run, cash-generating operator. For the six months to the end of June, revenue rose 10% to £133.1m, and the company's preferred profit measure — adjusted EBITDA less normalised rent, which strips out rent on leased sites to show what the estate actually earns — grew 12% to £30.8m, lifting its margin by half a percentage point to 23.1%. Adjusted profit before tax jumped 31% to £6.4m, and free cash flow rose 10% to £27.7m, while non-property net debt sat at £58m and leverage was unchanged at a comfortable 1.0x.

Average membership reached 1 million (1.002m for the half), and revenue per member per month climbed 5% to £22.14. Management then guided full-year EBITDA less rent to the top end of the analyst forecast range of £60.5m–£62m. A few days later, Deutsche Bank raised its price target from 230p to 260p. That is a coherent, improving picture, and it is why the market rewarded the shares.

Where the 10% growth actually comes from

Here is the part the headline buries. The like-for-like growth — the increase at sites that were already open — was only 3%, and management's own transcript says that 3% is essentially all price (revenue per member up, member volume at existing sites roughly flat). The gap between 3% and 10% is new gyms: the estate grew from 247 sites a year ago to 264.

That distinction matters, because it tells you this is a capital-funded growth story, not a same-store demand explosion. The plan is to open around 75 sites over three years, with at least 20 in 2026 alone, against full-year capital expenditure of £60m–£65m. The company insists the rollout is "funded from free cash flow," and on the current run-rate that is credible: free cash flow of £27.7m in the first half actually exceeded the half's total capex of £25.6m, and non-property net debt ended the half £1.3m lower than at the end of 2025, at £58m. That is the quiet strength of the model — the estate funds its own expansion without a leveraged bet.

But two caveats sit underneath that clean line. First, the surplus is not the whole story, because the spend is back-loaded: H1 capex of £25.6m already included a one-off ~£3.5m technology migration, yet only four of the year's at least 20 new sites opened in the first half, so the heavy lifting — and the cash outlay — lands in the second half, where the run-rate has to keep up with the £60m–£65m program. Second, the debt did drift up £6.8m year on year, and the borrowing facility was expanded to £117m in June — headroom that exists to be used, not an idle cushion. Leverage is still very safe at 1.0x against a 3.0x covenant, so this is not a balance-sheet risk. It is just worth noticing that the expansion's funding story, like its revenue story, leans on the second half holding up.

And the rollout is back-loaded. Only four sites opened in the first half; the company is aiming for at least 20 for the year, so most of the proof lands in the second half — the very window that gets priced into the share.

The business is good; is the stock good at 207p?

The cleanest way to think about it is to separate the two. The business: high-quality, compounding, with mature sites returning roughly 27%–30% on invested capital, member satisfaction above 94%, and a structural tailwind in UK gym penetration, which management puts at 17.6% and rising. That is a real and improving company.

The stock: it is now trading at roughly 39 times forward earnings, with a trailing multiple near 46 and a price-to-sales just under 1.5x, per Yahoo Finance data — and it is sitting near its 52-week high after a run of nearly 60%. The market is paying up front for the 75-site expansion and the assumption that same-store revenue keeps growing.

That is where the strongest bear facts sit, and they are all in management's own disclosures rather than invented. Competitor openings are already creating a 1%–2% drag on like-for-like volume. A small number of gyms remain loss-making, with about two closures expected in 2026 as leases expire. Statutory net margin is still thin, in the 3% range, so the national living wage and non-commodity energy costs can bite even with commodity rates fixed through late 2028. And management's most colorful new claim — that GLP-1 weight-loss users are spending more on fitness, a supposed structural tailwind — is a pitch, not yet something you can see in the reported numbers.

None of that breaks the business. But at 207p, a buyer is no longer getting a reset or a discount for that risk; they are being asked to own the execution of a back-loaded, capital-intensive rollout with limited cushion if the second half slips.

The setup for someone who has not bought

This is the difference between a good company and a good entry. The evidence says the operating case is solid and the guidance is credible, which is exactly why the stock is where it is. That leaves a new investor with a less lopsided risk/reward than the headline quarter implies: this is "own it for the compounding, or wait for a pullback," not a buy you must not miss.

A pullback toward the mid-160s to low-170s — a meaningful discount off the current 207p and back inside the middle of the 52-week range — while like-for-like volume holds and the second-half openings land, would be the kind of entry the fundamentals reward. What would genuinely change the view is a break on the metrics that carry the thesis: like-for-like volume turning negative as competitor openings press in, the rollout slipping on the back-loaded schedule, or the gap between free cash flow and capex widening to the point that leverage creeps meaningfully off 1.0x. Until one of those happens, the honest read is a business you can respect and a price that has largely absorbed the good news.